NASDAQ · HCWB
HCW Biologics Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HCWB: Nov 13, 2026
HCW Biologics Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-12.12.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews- RTTNews · Sep 24, 9:09 AM EDTHCW Biologics Prices $1.5M Private Placement(RTTNews) – HCW Biologics Inc. (HCWB) announced the pricing of a $1.5 million private placement with an existing stockholder, consisting of 903,614 units.
- RTTNews · Sep 11, 12:06 PM EDTWeekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials(RTTNews) – Biotech and healthcare saw regulatory approvals, strategic partnerships, M&A activity, and a steady stream of clinical trial updates driving investor attention.
- RTTNews · Sep 8, 10:16 AM EDTHCW Biologics Taps Akron Biotech To Market HCW11-006 For CAR-T Cell Production(RTTNews) – HCW Biologics Inc. (HCWB) announced that it has entered into an Exclusive Distribution Agreement with Akron Biotech to commercialize HCW11-006 as a reagent used to support the production of highly functional human CAR-T cells for cancer, autoimmune and infectious dise
- RTTNews · Sep 3, 3:16 AM EDTHCW Biologics Secures Patent Allowance For HCW9302 In Alopecia Areata; Phase 1 Data Due In Q4(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company, announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for claims directed to the use of HCW9302 to treat Alopecia Areata.
- RTTNews · Aug 25, 9:32 AM EDTHCW Biologics Advances Second-Generation Immunotherapeutics With TGF-ß/IL-15 Fusion(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for cancer, autoimmune diseases and senescence-associated diseases, announced new findings supporting its TGF-ß trap and IL-15 fusion as a potential immunotherap
- RTTNews · Aug 18, 9:59 PM EDTAfter-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWB(RTTNews) – Today's after-hours gainers include Tenon Medical, which recently reported its second-quarter results and implemented a reverse stock split; BioVie, which is developing a drug for early-stage Parkinson's disease; and Edesa Biotech, which is advancing EB06, a potential
- RTTNews · Aug 16, 9:57 PM EDTHCW Biologics Reports Wider Q2 Loss; Flags Going-Concern Risk; On Track For Phase 1 Data In Q4(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company, reported financial results for the second quarter reflecting a wider net loss. In addition, the company provided an update citing funding needs.
- RTTNews · Jun 26, 11:09 AM EDTHCW Biologics Sets 1-for-6 Reverse Stock Split For June 30; Shares Slide(RTTNews) – HCW Biologics Inc. (HCWB) announced a 1-for-6 reverse stock split that will take effect before markets open on June 30, 2026. The move is designed to help the company maintain its listing after receiving specific requirements from a Nasdaq Hearings Panel.
- RTTNews · Jun 26, 9:18 AM EDTHCW Biologics Commences 1-for-6 Reverse Stock Split(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company, Friday announced that it has been approved for a 1-for-6 reverse stock split of the company's common stock, with par value of $0.0001, effective June 30.
- RTTNews · May 21, 10:28 AM EDTHCW Biologics Prices $4 Million Private Placement To Advance Pipeline; Stock Down(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company developing fusion Immunotherapeutics for cancer, autoimmune disease, and age-related disorders, announced the pricing of a private placement valued at approximately $4.0 million.
- RTTNews · May 20, 10:19 PM EDTSLXN On Track, IMVT Hits New High, CTEV Eyes Blockbuster Revenue, Big Day Ahead For BDTX(RTTNews) – In today's gainers' list, we cover HCW Biologics, its upcoming catalysts and going concern risks; Silexion's development progress of its lead drug candidate SIL204; Immunovant's encouraging rheumatoid arthritis data; why investors will be closely watching Black Diamon
- RTTNews · May 18, 11:41 AM EDTHCW Biologics Records $3 Mln Net Income In Q1; Plans Phase 1 Data For Alopecia Drug In Q4(RTTNews) – HCW Biologics Inc. (HCWB), a clinical-stage biopharmaceutical company, on Thursday announced its first quarter financial results, and provided various business updates.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for HCW Biologics Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.